Skip to content

A secondary prevention patient centred model for smoking cessation.

A pilot study of a nurse-led evidence based smoking cessation program in smokers with cardiovascular disease to develop a secondary prevention model of care for smoking cessation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000016831
Enrollment
50
Registered
2012-01-04
Start date
2011-12-20
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study focuses on patients admitted to hospital with cardiovascular diseases. The cardiovascular system includes the heart and blood vessels that carry blood around the body. Smoking is one of the major risk factors for cardiovascular disease and following diagnosis individuals continue to smoke. We aim to particularly focus on these individuals for intensive treatment via a smoking cessation program. A specially trained Registered Nurse will undertake motivational interviewing techniques that consider the person’s readiness to change smoking habits and promote lifestyle changes. For further support a cardiologist and psychologist will be available for consultation.

Interventions

Motivational interviewing: Patients will be offered 6 face-to-face visits to a Registered Nurse, trained in smoking cessation techniques. The initial visit will be at least 90 minutes for assessment and counselling. Thereafter visits will be between 15 to 30 minutes for further counselling using evidence-based guidelines and carbon monoxide analysis to indicate abstinence. It is anticipated that most patients will remain engaged with the smoking cessation program for 3 months; however this cou

Motivational interviewing: Patients will be offered 6 face-to-face visits to a Registered Nurse, trained in smoking cessation techniques. The initial visit will be at least 90 minutes for assessment and counselling. Thereafter visits will be between 15 to 30 minutes for further counselling using evidence-based guidelines and carbon monoxide analysis to indicate abstinence. It is anticipated that most patients will remain engaged with the smoking cessation program for 3 months; however this could be extended to 6 months for those that need further support.

Sponsors

St Vincent’s Hospital Melbourne
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Primary diagnosis of one or more of the following: stable angina, atherosclerotic related events such as acute coronary syndrome, coronary artery bypass grafts, stroke, transient ischemic attack, or peripheral vascular disease. 2. Aged 18 and above 3. Telephone access 4. Current smoker 5. Fluent in English

Exclusion criteria

1. Diagnosed with a terminal illness 2. Cognitive impairment that may impact upon ability to participate in the trial 3. Participant is housebound 4. Participation in other research trial that may interfere with the trial 5. Inability to give informed consent 6. Any other factor impacting upon ability to give informed consent or participate in the study

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026